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Distinct midbrain dopamine (mDA) neuron subtypes
are found in the substantia nigra pars compacta
(SNc) and the ventral tegmental area (VTA), but it is
mainly SNc neurons that degenerate in Parkinson’s
disease. Interest in how mDA neurons develop has
been stimulated by the potential use of stem cells
in therapy or disease modeling. However, very little
is known about how specific dopaminergic subtypes
are generated. Here, we show that the expression
profiles of the transcription factors Sox6, Otx2,
and Nolz1 define subpopulations of mDA neurons
already at the neural progenitor cell stage. After
cell-cycle exit, Sox6 selectively localizes to SNc neu-
rons, while Otx2 and Nolz1 are expressed in a sub-
set of VTA neurons. Importantly, Sox6 ablation leads
to decreased expression of SNcmarkers and a corre-
sponding increase in VTA markers, while Otx2 abla-
tion has the opposite effect. Moreover, deletion of
Sox6 affects striatal innervation and dopamine
levels. We also find reduced Sox6 levels in Parkin-
son’s disease patients. These findings identify Sox6
as a determinant of SNc neuron development and
should facilitate the engineering of relevant mDA
neurons for cell therapy and disease modeling.INTRODUCTION
Midbrain dopamine (mDA) neurons constitute a highly diverse
neuronal population controlling important brain functions such
as voluntary movements, cognition, and reward. Progressive
degeneration of mDA neurons causes severe motor symptoms
in Parkinson’s disease, and altered dopamine (DA) neurotrans-1018 Cell Reports 8, 1018–1025, August 21, 2014 ª2014 The Authormission is associated with addiction and psychiatric disease.
mDA neurons can be subdivided into major anatomically and
functionally distinct cell groups, including the substantia nigra
pars compacta (SNc) (A9) and ventral tegmental area (VTA;
A10) (Bjo¨rklund and Dunnett, 2007; McRitchie et al., 1996).
SNc neurons innervate the dorsal/lateral striatum and are critical
for controlling motor functions, while neurons within the VTA
innervate cortical and limbic areas and are primarily associated
with emotional behaviors. Notably, cells within the SNc are the
most vulnerable mDA neurons and are severely affected in Par-
kinson’s disease (Damier et al., 1999; Fearnley and Lees, 1991).
AllmDAneurons arederived fromacommonpopulationof neu-
ral progenitor cells localizedwithin theventralmidbrainandcaudal
diencephalon (Marı´n et al., 2005). Signaling molecules including
Sonic hedgehog (Shh), fibroblast growth factor (FGF) 8, andmem-
bers of the Wnt family of secreted glycoproteins play key roles in
establishing expression of transcription factors such as Lmx1a,
Lmx1b, Otx2, and FoxA2 in mDA neural progenitors (e.g., Ander-
sson et al., 2006; Castelo-Branco et al., 2003; Ferri et al., 2007;
Prakash et al., 2006; Puelles et al., 2004; Smidt et al., 2000). Prolif-
erating progenitor cells will eventually exit the cell cycle, migrate
toward their final destinations, andbegin to express pan-neuronal
and mDA neuron-specific genes, including tyrosine hydroxylase
(TH) and the dopamine transporter (DAT). Although considerable
progress hasbeenmade inunderstandingkeyeventsdetermining
the generation of all mDA neurons, remarkably little is known of
how distinct subpopulations are specified during embryogenesis.
Previous characterization has revealed molecular differences be-
tween SNc and VTA neurons, but it has remained unclear at what
developmental stageSNc and VTAneurons first becomemolecu-
larly distinct (Chung et al., 2005; Wolfart et al., 2001). Recently, it
was shown that the transcription factorOtx2 is involved in control-
ling the subtype identity of VTA neurons. Otx2 is first expressed in
neural progenitor cellsandmaintained inasubsetofdifferentiating
and mature VTA neurons (Chung et al., 2010; Di Salvio et al.,
2010b). Gain- and loss-of-function analysis both in progenitor
cells and postmitotic neurons demonstrated a role of Otx2 ins
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Figure 1. Sox6 and Nolz1 Are Selectively Expressed in SNc and VTA
Dopamine Neurons, Respectively
(A–H) Immunohistochemical analysis of Sox6 and Nolz1 expression in com-
bination with TH in SNc and VTA neurons in E18.5 embryos and P120 adult
mice. Arrowheads indicate Sox6-expressing mDA neurons in SNc (A and C)
and the few expressing cells in the VTA (E and G). Arrowheads in (F) and (H)
point to Nolz1-expressing cells in VTA dopamine neurons.
(I–L) Fluorogold (FG) retrograde tracing analysis. (I) FG was unilaterally injected
in the adult dorsal-lateral striatum (n = 4). The injection site in the striatum
(outlined by dashed line) is evident 24 hr after injection. (J) FG selectively labels
SNc dopamine neurons, but not the VTA. (K) High-magnification image of SNc
showing FG labeling of TH+ neurons. (L) Most FG-positive SNc dopamine
neurons are positive for Sox6.
Scale bars, 100 mm. See also Figure S1.promotingVTAsubtype identity (Chungetal., 2010;DiGiovannan-
tonio et al., 2013; Di Salvio et al., 2010a). In addition, SNc neurons
are selectively lost in mice deficient for the transcription factor
Pitx3 (Hwang et al., 2003; Nunes et al., 2003; Smidt et al., 2004;
van den Munckhof et al., 2003). However, Pitx3 is expressed at
a relatively late postmitotic stage in all mDA neurons and is not
involved in early specification events. Therefore, additional tran-
scription factors controlling lineage selection into SNc mDA neu-
rons need to be identified.
We previously identified the transcription factors Sox6 and
Nolz1 (also referred to as Zfp503) in a screen formDA neuron-ex-
pressed genes (Panman et al., 2011). Both Sox6 and Nolz1 are
important for neuronal subtype diversification in other brain
regions (Azim et al., 2009; Batista-Brito et al., 2009; Chang
et al., 2013; Ji et al., 2009). Here, we show that the expression
of Sox6 and Nolz1 define distinct populations of mDA neuron
progenitors and identify Sox6 as a key transcription factor for
the specification and development of SNc mDA neurons.
RESULTS
Sox6, Otx2, and Nolz1 Are Selectively Expressed in
Distinct Dopaminergic Neuronal Subpopulations
We examined the localization of Sox6 and Nolz1 in embry-
onic and adult dopaminergic neurons. ImmunohistochemistryCelshowed Sox6 or Nolz1 expression in distinct mDA neuron sub-
populations at embryonic day 18.5 (E18.5) and in the adult brain
(Figure 1; Figure S1). While Sox6 was expressed in the lateral
population of TH-positive neurons corresponding to the SNc
(approximately 95% at E18.5 and 85% in adults) and in only a
few scattered cells in the dorsal VTA, Nolz1 was selectively ex-
pressed in a subpopulation of VTA neurons in the E18.5 (approx-
imately 18%; data not shown) and adult (postnatal day 120
[P120]; fewer than 10%) ventral midbrain (Figures 1A–1H). Ana-
lyses of additional markers confirmed the restricted expression
of Sox6 to SNc neurons that innervate the dorsal striatum.
Sox6 expression in the SNc overlaps with Girk2 and glycosylated
DA transporter (GlycoDAT) and partly with Raldh1, but not with
the VTA markers Calbindin and Otx2 at E18.5 and in adults (Fig-
ure S1). We performed retrograde tracing by injecting fluorogold
into the adult dorsal-lateral striatum leading to retrograde label-
ing of neurons within the SNc, but not within the VTA (Figures 1I–
1K). Importantly, the majority of fluorogold-positive cells were
also positive for Sox6 (Figure 1L). Moreover, Sox6 expression
was diminished while Nolz1 was maintained in Pitx3 mutant
mice, which is consistent with selective loss of SNc mDA neu-
rons in these animals (Figure S2). Thus, Sox6 expression is
predominantly restricted to mDA neurons that innervate the
dorsal-lateral striatum. Sox6 is also expressed in interneurons
in the dorsal midbrain at E15.5 and E18.5 as shown by in situ
hybridization and in additional uncharacterized cell types (Fig-
ure S2 and data not shown).
The expression of Sox6, Nolz1, and Otx2 was analyzed
at stages when mDA neurons become specified (E11.5 and
E13.5; Figure 2). The transcription factor Lmx1a was selectively
expressed in all progenitor cells that give rise to mDA neurons
(Andersson et al., 2006). In contrast, Sox6, Nolz1, and Otx2
were expressed in distinct subpopulations of mDA neuron pro-
genitor cells at E11.5 (Figures 2A–2E). While Sox6 was detected
in the medial Corin+ and Lmx1a+ progenitor domain, Nolz1
expression was localized laterally (Figures 2A–2E; Figure S2).
Double Sox6 and Nolz1 staining showed that the expression of
these factors was mutually exclusive in medial and lateral mDA
progenitors, respectively (Figure 2D). In addition, Otx2 was ex-
pressed only at low levels in medial Sox6+ progenitors (Figures
2C and 2E) but was strongly expressed within Nolz1+ lateral cells
(Figures 2C and 2E). Thus, mDA neuron progenitors are orga-
nized in molecularly distinct medial (Sox6+/Otx2weak/Nolz1)
and lateral (Sox6/Otx2strong/Nolz1+) domains. In early postmi-
totic neurons, a few cells express both Sox6 and Otx2 (arrows
in Figures 2A, 2C, and 2D). These cells appear to be immature
mDA precursor cells that express the general mDA neuron tran-
scription factor Nurr1, but not TH (Figure S2).
To further understand how SNc and VTA neurons are speci-
fied, expression of Sox6, Otx2, and Nolz1 was analyzed after
progenitor cell-cycle exit when cells are acquiring dopaminergic
traits and begin tomigrate toward their final destinations (Figures
2F–2Q). At E13.5, Sox6 and Nolz1/Otx2 were expressed in a
nonoverlapping pattern in postmitotic differentiating neurons
(Figures 2F–2K). Postmitotic Sox6+ mDA neurons were found
medially within the intermediate zone in the mDA domain and
extended laterally along the marginal zone (Figures 2F, 2G, and
2I). Thus, cells leaving themedial Sox6+ progenitor zone seemedl Reports 8, 1018–1025, August 21, 2014 ª2014 The Authors 1019
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Figure 2. Spatial and Temporal Dynamics of Sox6, Nolz1, and Otx2 Expression in the Developing Ventral Midbrain
(A–E) Combinatorial expression analysis using antibodies against Sox6, Lmx1a, Nolz1, and Otx2 in E11.5 ventral midbrain reveals a distinct lateral and medial
progenitor domain. Medially located Sox6 expressionwithin Lmx1a+ progenitor domain (asterisk). Arrows in (A) and (D) point to immature postmitoticmDA neuron
precursors. Arrows in (C) point to Otx2+Sox6+ postmitotic mDA precursor cells.
(F–K) Expression of Sox6, Nolz1, Otx2, and TH at E13.5. A subset of Otx2+ neurons expresses Nolz1 (arrows in H), while the more medially positioned Otx2+ cells
are Nolz1 (arrowheads). Sox6 is expressed in medially located TH+, while its expression extends laterally at the marginal zone (arrows in I). Nolz1- and Otx2-
expressing TH-positive neurons are located laterally (arrows in J and K).
(L–Q) Expression of Sox6, Nolz1, and Otx2 in the SNc and VTA at E18.5. Sox6 is expressed in SNc dopamine neurons (L and M), while Otx2 and Nolz1 are absent
(L, M, and N). (O–Q) Nolz1 and Otx2 are expressed in VTA dopamine neurons. Few Sox6-positive mDA neurons can be found in the dorsal-lateral VTA
(arrowheads in O and P). Arrows in (P) point to rarely observed Sox6+Otx2+ neurons. (Q) Nolz1 is expressed in a subset of Otx2+ VTA neurons (arrowheads).
(R) Schematic representation summarizing the distribution of cell populations at E11.5, E13.5, and E18.5. See text for details.
Scale bars, 100 mm. See also Figure S2.to migrate ventrally and then laterally to end up in the lateral
SNc at E18.5 (Figures 2L–2Q). Postmitotic Otx2+ and Nolz1+
cells were instead positioned in two vertical stripes extending
ventrally from the lateral Nolz1+ progenitor domain (Figures 2F,
2G, 2J, and 2K). At E13.5, Nolz1 was already confined to the
most lateral subpopulation of Otx2+ neurons in a pattern that
was maintained in the VTA at E18.5, where Nolz1 was also ex-
pressed in the most dorsal-lateral Otx2+ VTA neurons (Figures
2F, 2H, 2J, and 2Q).
These findings lead to two conclusions concerning the origin
of SNc and VTA neurons (illustrated in Figure 2R). First, prolifer-
ating cells within the Lmx1a+ progenitor zone have already
acquired a distinct molecular character that is related to the sub-
sequent generation of SNc and VTA neurons. This is defined by
the mutually exclusive expression of Sox6 or Nolz1 and the dif-
ferential expression of Otx2 (weak in the medial but strong in
the lateral region). Second, the expression pattern indicates a
dynamic ‘‘inside-out’’ migration of medial Sox6+/Otx2weak cells
to the positions occupied by laterally located SNc-forming
mDA neurons, while Nolz1+/Otx2strong cells originate from a1020 Cell Reports 8, 1018–1025, August 21, 2014 ª2014 The Authorlateral position in the ventricular progenitor zone to settle in the
medially located VTA (Figure 2R).
Otx2 Suppression of Sox6 and Altered SNc-Specific
Neuronal Character in Sox6/ Mutant Embryos
The complementary expression of Sox6 and Otx2 during early
mDA neuron progenitor specification (medial: Sox6+/Otx2low;
lateral: Sox6/Otx2high) indicates that these transcription factors
might cross-regulate each other. Indeed, by conditional ablation
ofOtx2 in ventral progenitors (Di Giovannantonio et al., 2013), we
note that Sox6 expression was expanded laterally (Figure 3A). As
shown previously, Otx2 ablation results in a severely diminished
generation of VTA neurons (Di Giovannantonio et al., 2013). Inter-
estingly, remaining postmitotic neurons positioned in the VTA
region of Otx2-ablated embryos expressed ectopic Sox6 (Fig-
ure 3A). In addition, overexpression of Otx2 in postmitotic SNc
neurons in vivo suppressed Sox6 expression (Figure S3), while
ablation of Otx2 in postmitotic neurons did not result in the
expansion of Sox6 expression domain. Thus, Otx2 is essential
for restricting the expression of Sox6 in medial mDA progenitorss
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Figure 3. Otx2 and Sox6 Have Distinct Roles
in mDA Subtype Specification
(A) Ablation of Otx2 in E11.5 ventral midbrain re-
sults in a lateral expansion of the Sox6 expression
domain (indicated with a bracket). Asterisk in-
dicates the ventral midline.
(B) Otx2 expression remains unaltered in ventral
midbrain of E12.5 Sox6 mutant embryos.
(C) Immunohistochemistry showing ventral
midbrain distribution of Calbindin (Calb) and TH in
the SNc at E18.5 in wild-type and Sox6/ em-
bryos, respectively. Arrows point to Calb-labeled
TH+ neurons.
(D) Immunohistochemistry showing ventral
midbrain distribution of Raldh1 and TH in the
SNc at E18.5 in wild-type and Sox6/ embryos,
respectively. Arrows point to Raldh1-labeled TH+
neurons.
(E) Immunohistochemistry showing ventral
midbrain distribution of GlycoDAT and TH in the
SNc at 18.5 in wild-type and Sox6/ embryos,
respectively. Arrows point to GlycoDat-negative
TH+ neurons.
(F) Percentage of TH+ neurons expressing Calbin-
din (Calb), GlycoDat, or Raldh1 in wild-type and
Sox6/ embryos (n = 3), respectively; mean
values ± SD; **p < 0.01.
(G) Images represent coronal sections through the
striatum of an E18.5 embryo stained with Dat to
visualize Dat-expressing fibers. Area 1 marks the
lateral part of the striatum, while area 2 marks the
medial part.
(H) Immunohistochemistry of DAT innervation
analyzed by densitometry in a lateral (area1) and
medial (area 2) region of the striatum in wild-type
and Sox6/ embryos, respectively (n = 4); mean
values ± SD; *p < 0.05, **p < 0.01.
(I) In situ hybridization using a probe against Epha5
in wild-type and Sox6/ embryos, respectively.
Dashed circle marks the location of SNc dopamine
neurons in the E18.5 embryo.
Scale bars, 100 mm. See also Figure S3.and sufficient for the suppression of Sox6 expression in post-
mitotic mDA neurons.
To analyze the role of Sox6 in suppression of Otx2 and in the
generation of SNcmDA neurons, Sox6 null (Sox6/) mutant em-
bryos were studied (Dumitriu et al., 2006). Expression of neither
Otx2 nor Nolz1 was increased in Sox6/mutant progenitor cells
or postmitotic neurons (Figure 3B and data not shown). How-
ever, although the number of TH+ dopaminergic neurons was
unchanged (data not shown), notable differences between geno-
types were seen. The number of neurons within the SNc that
expressed the VTA marker Calbindin was markedly increased
in E18.5 Sox6/ embryos (Figures 3C and 3F). The glycosylated
form of DAT (GlycoDAT) was strongly expressed in SNc mDA
neurons and in a dorsal-lateral population in the VTA in wild-
type embryos. In contrast, neurons that were negative for
GlycoDAT expression were significantly increased in Sox6/
SNc (Figures 3E and 3F), while expression of the Raldh1 in the
SNc was reduced (Figures 3D and 3F).CelIn addition, at E18.5, striatal fiber innervation was affected in
Sox6/ mutant embryos as shown by 3,30-diaminobenzidine
immunoperoxidase (DAB) staining for DAT and TH, respectively
(Figures 3G and 3H; Figure S4). Notably, the lateral striatal region
(area 1; Figure 3G), which is mainly innervated by SNc mDA neu-
rons, was markedly less intensely stained as shown by densi-
tometry using antibodies against both DAT and TH (Figure 3H;
Figure S4). The more medial (area 2) and ventral striatum, which
is predominantly innervated by VTA mDA neurons, showed
normal TH and DAT immunostaining intensity (Figures 3G and
3H; Figure S4). In addition, expression of the ephrin receptor
Epha5 was selectively expressed in SNc neurons in wild-type
embryos and strongly reduced in Sox6/ animals, as deter-
mined by in situ hybridization analysis (Figure 3I). Thus, the
reduced innervation of the lateral part of the striatum could be
due to a defect in the axonal guidance pathway, but it may
also be influenced by other deficiencies in SNc mDA neurons.
The expression of several other axon-guidance molecules andl Reports 8, 1018–1025, August 21, 2014 ª2014 The Authors 1021
general mDA neuron markers including Lmx1a, Pitx3, En1, and
Nurr1 were unchanged (data not shown). Taken together, these
data show that Otx2 plays a critical role in the suppression of
Sox6 inmDA neuron progenitors and postmitotic neurons.More-
over, although a complete transition in phenotype from SNc to
VTA neurons does not occur as a consequence of Sox6 ablation,
the results clearly indicate that Sox6 plays an important role in
promoting SNc-specific and suppressing VTA-specific charac-
teristics in mDA neurons.
Sox6 Is Essential in Postmitotic SNc Neurons and Is
Expressed in Human SNc mDA Neurons
Sox6/ mice do not survive after birth because of deficiencies
that are unrelated to the phenotype in mDA neurons (Smits
et al., 2001). To analyze the role of Sox6 in postmitotic mDA
neurons, floxed Sox6 mice were crossed with DatCre mice to
selectively inactivate Sox6 in Dat-expressing postmitotic mDA
neurons (Kadkhodaei et al., 2009). Within the ventral midbrain,
the number of mDA neurons appeared intact in DatCre/+;Sox6fl/fl
mutant embryos and adult mice (data not shown). However,
there was a reduced density of dendritic TH
+
fibers in the ventral
midbrain of 4- and 8-month-old mutant mice (Figure 4D). In addi-
tion, while the striatal innervation in E18.5 DatCre/+;Sox6fl/fl
mutant embryos appeared normal (Figure S3), TH+ fiber density
in the striatum of 4-month-old mutant mice was clearly reduced
(area 1; Figures 4A and 4C; Figure S4). The intensity of mDA
neuron fiber density was further decreased in the dorsal-lateral
part of the striatum of DatCre/+;Sox6fl/fl in 8-month-old animals
(Figures 4B and 4C; Figure S4), while the innervation of the
ventral striatum remained unaffected (Figures 4A–4C). Impor-
tantly, the affected striatal region is primarily innervated from
Sox6+ SNc mDA neurons. Other analyzed regions within the
hippocampus and amygdala appeared unaffected (data not
shown). In addition, TH+ cell bodies within the VTA in 8-month-
old mutant mice also appeared normal (Figure S4). Furthermore,
consistent with a decreased striatal fiber innervation, DA and DA
metabolites (DOPAC and HVA) were reduced in the caudate
putamen (CPu) of Sox6 conditionally ablated mice (Figure 4E),
while levels within VTA-innervated nucleus accumbens were
not significantly altered (Figure S4). Further, the open field test
showed that Sox6 conditional knockout mice were more active
compared to controls (Figure S4), a behavior that has previously
been shown to result from prenatal SNc mDA neuron deficiency
(e.g., Hwang et al., 2005). Thus, ablation of Sox6 within differ-
entiating mDA neurons demonstrates an important role in main-
taining SNc, but not VTA, characteristics in mDA neurons.
The results showing that Sox6 is important for maintaining
normal postmitotic SNc mDA neuron properties in mice raise
the question of how Sox6 is expressed in the normal and
diseased human brain. Postmortem tissue samples from both
Parkinson’s disease brains and aged-matched controls were
analyzed by Sox6 immunostaining (Figures 4F–4H). Sox6 stain-
ing was clearly detectable and localized to neuromelanin and
TH-positive neurons in the SNc (Figure 4F; Figure S4). Sox6
expression was not observed in medial neuromelanin-negative
neurons (data not shown), but we could not firmly conclude
whether these neurons are VTA neurons. Thus, Sox6 expression
in the human mDA neurons is likely recapitulating that seen in1022 Cell Reports 8, 1018–1025, August 21, 2014 ª2014 The Authormice. To analyze whether Sox6 expression is affected in Parkin-
son’s disease, we compared the levels of Sox6 expression by
densitometry in 145 individual neuromelanin-positive cells in
controls (n = 4) and 323 neuromelanin-positive cells in Parkin-
son’s disease tissue samples (n = 8). Interestingly, a significant
reduction of Sox6 staining in Parkinson’s disease patients
compared to controls was evident when considering measure-
ments in all individual neurons (Figure 4G) and averages in stain-
ing intensities determined for each control and each Parkinson’s
disease patient (Figure 4H). Thus, Sox6 expression is clearly
diminished in neuromelanin-positive neurons in Parkinson’s
disease patients.
DISCUSSION
The importance of mDA neurons in normal brain function and
their degeneration in Parkinson’s disease has placed this cell
population at central stage in studies of lineage-specific neuro-
genesis during CNS development. An important motivation to
understand how these cells develop originates from strong inter-
est in developing methods for stem cell engineering of mDA
neurons to be used in cell therapy or for disease modeling in
cell culture (Cooper et al., 2012; Lindvall and Bjo¨rklund, 2011;
Studer, 2012). However, although signaling and transcription
factor pathways controlling generic aspects of mDA neuron
specification and differentiation are beginning to be understood,
the processes regulating mDA neuron diversity have remained
mostly unclear. In this study, we elucidated a transcription factor
code that subdivides the Lmx1a+ progenitor pool in lateral
(Otx2highNolz1+Sox6) and medial (Otx2lowNolz1Sox6+) do-
mains, respectively. After cell-cycle exit, these transcription
factors are expressed in a corresponding way in VTA
(Otx2+Nolz1+Sox6) and SNc (OtxNolz1Sox6+) postmitotic
mDA neurons. This coordinated expression before and after
cell-cycle exit suggests that subtype identities have already
been determined in mDA neural progenitors. The finding that
Sox6+ progenitor cells reside in medial domain while Nolz1+
and Otx2high progenitors are found in a lateral Sox6 region
also indicated an intriguing, and somewhat counterintuitive, in-
side-out migration of developing SNc mDA neurons (Figure 2R).
Interestingly, recent fate-mapping studies using temporally
controlled Cre expression in reporter mice support the conclu-
sion that SNc neurons originate from medial mDA progenitor
cells (Blaess et al., 2011; Bodea et al., 2014; Joksimovic et al.,
2009).
Using two different mouse ablation strategies, we demon-
strated that Sox6 is required for the normal development of
SNc neurons and maintenance of some SNc-specific neuronal
properties. Together, the data reveal both early and late roles
for Sox6 in SNc neurons. Our finding that Sox6 ablation by Dat-
Cre leads to decreased density of TH+ fibers in the dorsal-lateral
striatum and a corresponding decrease in the levels of striatal DA
is intriguing when considering our observation that Sox6 expres-
sion is diminished in neuromelanin-positive neurons in Parkin-
son’s disease patients. Interestingly, a recent study identified a
mutation within the human Sox6 gene leading to a general
developmental delay and parkinsonian symptoms in an affected
child (Scott et al., 2014). A decrease in Sox6 in association withs
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Figure 4. Sox6 Is Required for the Functional Integrity of SNc Neurons in Adult Mice
(A) Immunohistochemical analysis of TH+ fiber innervation in the striatum of 4-month-old DatCre;Sox6fl/+ and DatCre;Sox6fl/fl mice. Area 1 represents the dorsal-
lateral part of the striatum, while area 2 represents the ventral part of the striatum.
(B) Immunohistochemical analysis of TH expression in the striatum of 8-month-old DatCre;Sox6fl/+ and DatCre;Sox6fl/fl mice.
(C) Analysis of TH-expressing fibers in the striatum by densitometry in a dorsolateral (area1) and medial (area 2) region of the striatum at 4 and 8 months in
DatCre;Sox6fl/+ and DatCre;Sox6fl/fl mice, respectively. (n = 4); mean values ± SD; *p < 0.05; **p < 0.01.
(D) Analysis of TH expression in midbrain of 4- and 8-month-old DatCre;Sox6fl/+ and DatCre;Sox6fl/fl mice. Scale bars in (A)–(D), 200 mm.
(E) DA and DAmetabolites (DOPAC and HVA) analyzed by high-performance liquid chromatography from extracts of the dorsolateral part of the striatum (area 1)
of 6-month-old DatCre;Sox6fl/+ and DatCre;Sox6fl/fl mice (n = 10). Values are shown as percentages relative the levels detected in extracts from DatCre;Sox6fl/+
mice (100%); mean values ± SD; *p < 0.05; **p < 0.01.
(F) Sox6 expression in the human SNc. Expression analyzed by immunohistochemistry for Sox6 is shown in sections from two controls and two individuals with
Parkinson’s disease (PD1 and PD2). Distribution of Sox6 (dark blue) is localized to neuromelanin-positive (brown) neurons in the SNc of control individuals
(arrows), while nuclear Sox6 expression is not observed in PD patient 1 and only weakly observed in some nuclei of PD patient 2 (arrowheads). Scale bar, 25 mm.
(G) Intensity of Sox6 levels in individual neuromelanin-positive neurons (n = 323) is decreased in in Parkinson’s disease patients compared to neurons (n = 145) in
controls. Intensity was measured by densitometry and shown for each cell in arbitrary units; mean values ± SEM; ***p < 0.001.
(H) The intensities from the individual cells (shown in G) is averaged for each Parkinson’s disease patient (n = 8) or control (n = 4) and determined in arbitrary units;
mean values ± SEM; *p < 0.05. See also Figure S4.Parkinson’s disease pathologymay thus contribute to continuing
deterioration of SNc mDA neurons in this disease.
From the data reported here and from previous studies on
Otx2, it should be noted that neither Otx2 nor Sox6 ablation led
to a complete cell-fate transition of subtype identities (Di Giovan-Celnantonio et al., 2013; Di Salvio et al., 2010b). Thus, we postulate
that additional factors contribute to lineage selection of VTA and
SNc neurons. It is interesting that Nolz1 is expressed strictly in
lateral neural progenitors in which Otx2 is also highly expressed.
An intriguing possibility is that Otx2 and Nolz1 functionallyl Reports 8, 1018–1025, August 21, 2014 ª2014 The Authors 1023
interact to determine the VTA neuronal fate. It is also important to
note that the diversity of mDA neuron types extends beyond the
division into SNc and VTA neurons. Thus, another major mDA
neuron group localized in the retrorubral field (A8) has properties
that are distinct from those in the SNc and VTA (Bjo¨rklund and
Dunnett, 2007), and within the substantia nigra and VTA, molec-
ularly and functionally diverse mDA neuron subpopulations have
also been described (see e.g. Di Salvio et al., 2010a; Fu et al.,
2011; Roeper, 2013). How Sox6, Otx2, Nolz1, and other tran-
scription factors influence additional complexity within mDA
neurons therefore remains an important question to investigate.
The studies presented here have important implications for
stem cell engineering. Cell transplantation in Parkinson’s dis-
ease animal models has demonstrated that Girk2+ SNc neurons
must be a major constituent of cell grafts to restore lost motor
function in Parkinson’s disease (Cooper et al., 2012; Grealish
et al., 2010; Zuddas et al., 1991). The identification of Sox6
and Nolz1 as two early progenitor markers for prospective SNc
and VTA neurons, respectively, will provide a valuable tool in
tracing how different culturing conditions affect lineage selection
at very early stages in stem cell differentiation experiments. This,
in turn, should facilitate possibilities to identify culturing condi-
tions resulting in SNc or VTA mDA neuron-enriched cultures
(Studer, 2012).
EXPERIMENTAL PROCEDURES
Mouse Strains
Sox6fl/+ animals (Dumitriu et al., 2006) were crossed with DatCre/+;Sox6fl/+ ani-
mals (Ekstrand et al., 2007) to obtainDatCre/+;Sox6fl/flmutant offspring.Sox6/
mutant embryos were obtained from crossings between Sox6+/ heterozygous
mice.Otx2mutantmousestrainswerekept andbredasdescribedpreviously (Di
Giovannantonio et al., 2013; Di Salvio et al., 2010a). All animal experimentswere
approved by the local animal ethics committee and conform to the relevant reg-
ulatory standards. For details, see Supplemental Experimental Procedures.
Immunohistochemistry
Embryos were fixed for 1–3 hr in 4% paraformaldehyde (PFA) and further pro-
cessed as described before (Briscoe et al., 2000). Adult mice were perfused
with 4% PFA as described previously (Kadkhodaei et al., 2009), and dissected
brains were postfixed for 4 hr in 4%PFA. For details, see Supplemental Exper-
imental Procedures.
Human Postmortem Tissue
Paraffin-embedded midbrain sections from Parkinson’s disease patients
(n = 8) and age-matched control individuals (n = 4) were provided by the UK
Parkinson’s Disease Society Tissue Bank at Imperial College. For details,
see Supplemental Experimental Procedures.
Statistical Analysis
Statistical significance was calculated by the one-paired Student’s t test, and
data are presented as mean ± SD (*p < 0.05, **p < 0.01).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2014.07.016.
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